Stacey L. Berg, MD


  • Texas Medical Center



Phone: 832-824-4588
Fax: 832-825-4039

Contact Information

1102 Bates
Suite 1550.06
Houston, TX 77030
United States

Director, Palliative Care Program
Director, Developmental Therapeutics Program

Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine


School Education Degree Year
NIH/NIAID fellowship Pediatric Hematology Oncology 1994
University of Pittsburgh School of Medicine residency Pediatrics 1988
University of Pittsburgh School of Medicine internship Pediatrics 1986
University of Pittsburgh School of Medicine medical school Doctor of Medicine 1985


Dr. Stacey Berg is the Director of both the Developmental Therapeutics Program and the Palliative Care Program at Texas Children's Cancer and Hematology Centers. Dr. Stacey Berg's primary area of interest is pharmacology and experimental therapeutics, with a special emphasis on the development of new anticancer drugs for children. Her clinical interests include: pharmacology, new drug development, and hospice and palliative care.


Organization Name Role
American Academy of Hospice and Palliative Medicine Member
American Academy of Pediatrics (AAP) Member
American Association for Cancer Research (AACR) Member
American Society Clinical Oncology (ASCO) Member
Children's Oncology Group (COG) Developmental Therapeutics Steering Committee

Research Statement

In addition to these, Dr. Stacey Berg also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.

In the laboratory, Dr. Berg's interests include preclinical investigation of the pharmacokinetics of new agents. Drug concentrations are determined by high-pressure liquid chromatography or other appropriate methods. Data are analyzed with a variety of computer modeling strategies. These data facilitate the development of new therapies of children with cancer.

Selected Publications

Related Videos

  • Embedded thumbnail for Relapse & Developmental Therapeutics
    Relapse & Developmental Therapeutics